Loading cancer entity…
Loading cancer entity…
Clinical trials
58 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (8)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02623127 | A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma(KOSMIC) | completed | Phase 2 | 25 | Seoul National University HospitalOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT01100944 | A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies | terminated | Phase 1 / Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Aug 10, 2017 |
| clinicaltrials |
| NCT03170804 | Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer | unknown | — | 200 | Aventura Hospital and Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00965250 | Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy | completed | Phase 2 | 49 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2016 | clinicaltrials |
| NCT00589290 | Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage | completed | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2015 | clinicaltrials |
| NCT00314873 | Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma | completed | Phase 1 | 11 | Indiana UniversityOTHER | 1 | Jun 3, 2014 | clinicaltrials |
| NCT00818090 | Paclitaxel and Cisplatin for Thymic Neoplasm | terminated | Phase 2 | 39 | Korean Cancer Study GroupOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00003662 | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases | completed | Phase 2 | 90 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Jan 23, 2019source: clinicaltrials